Immorta Bio

Seed
immortabio.com Biotech & Healthcare Miami Beach, United States
Total Funding Undisclosed
Latest Round Undisclosed Seed
Last Announced Oct 16, 2026
Investors Undisclosed
Decision Makers 2 Verified

About Immorta Bio

Immortabio is a biotechnology company developing AI-enabled personalized therapeutics to treat diseases of aging.

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Seed
Global Headquarters Miami Beach, United States
Tracked Since Oct 20, 2026

Web & Domain Identity

Official Website immortabio.com
Domain Registered Date Aug 30, 2023

Social & Network Presence

X / Twitter Profile @ImmortaBio (1.6K followers) Created on Oct 2023
LinkedIn Corporate Company Profile

Company Milestones & Timeline

3 Events
  1. Capital Raise

    Seed announced

  2. Milestone

    X account created (@ImmortaBio)

    1.6K followers

  3. Milestone

    Website domain registered

    immortabio.com

Investors & Backers

Investor firms and individual backers were not publicly disclosed in available round filings for Immorta Bio.

Funding History

1 Round
Seed equity · Oct 16, 2026
Undisclosed

Founders & Leadership

4

Armin Rath

Chief Business Officer

Work email & phone locked Unlock →

Boris Reznik

CEO

Work email & phone locked Unlock →

Thomas Ichim

President and Chief Scientific Officer

Work email & phone locked Unlock →

Vlad Bykoriz

Chief Medical Officer

Work email & phone locked Unlock →

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

START FREE WITH 50 CREDITS
Recently funded startups
New SaaS launches
Never pay twice for contacts